Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Frank H Ebetino"'
Autor:
Hiroko Okawa, Takeru Kondo, Akishige Hokugo, Philip Cherian, Jesus J Campagna, Nicholas A Lentini, Eric C Sung, Samantha Chiang, Yi-Ling Lin, Frank H Ebetino, Varghese John, Shuting Sun, Charles E McKenna, Ichiro Nishimura
Publikováno v:
eLife, Vol 11 (2022)
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents as a morbid jawbone lesion in patients exposed to a nitrogen-containing bisphosphonate (N-BP). Although it is rare, BRONJ has caused apprehension among patients and healthcare providers
Externí odkaz:
https://doaj.org/article/e3ceccf5a73f432bb37f38fa3f67e062
Autor:
Marcia A Munoz, Emma K Fletcher, Oliver P Skinner, Julie Jurczyluk, Esther Kristianto, Mark P Hodson, Shuting Sun, Frank H Ebetino, David R Croucher, Philip M Hansbro, Jacqueline R Center, Michael J Rogers
Publikováno v:
eLife, Vol 10 (2021)
Bisphosphonates drugs target the skeleton and are used globally for the treatment of common bone disorders. Nitrogen-containing bisphosphonates act by inhibiting the mevalonate pathway in bone-resorbing osteoclasts but, surprisingly, also appear to r
Externí odkaz:
https://doaj.org/article/efd2366c282f45e0a4b6b5d87db2968d
Autor:
Abigail A Coffman, Jelena Basta‐Pljakic, Rosa M Guerra, Frank H Ebetino, Mark W Lundy, Robert J Majeska, Mitchell B Schaffler
Publikováno v:
JBMR Plus, Vol 5, Iss 7, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/39b83b895613419fbd0d9763b0efaee3
Autor:
Abigail A Coffman, Jelena Basta‐Pljakic, Rosa M Guerra, Frank H Ebetino, Mark W Lundy, Robert J Majeska, Mitchell B Schaffler
Publikováno v:
JBMR Plus, Vol 5, Iss 4, Pp n/a-n/a (2021)
ABSTRACT Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about bone health based on oversuppression of remodeling remain. Long‐term bone remodeling suppression adversely affects bone material properties with microd
Externí odkaz:
https://doaj.org/article/7379c21f04d841a7a77d926f4a2a7532
Autor:
Zhenqiang Yao, Akram Ayoub, Venkatesan Srinivasan, Jun Wu, Churou Tang, Rong Duan, Aleksa Milosavljevic, Lianping Xing, Frank H. Ebetino, Alison J. Frontier, Brendan F. Boyce
Publikováno v:
Bone Research, Vol 12, Iss 1, Pp 1-11 (2024)
Abstract Osteoporosis remains incurable. The most widely used antiresorptive agents, bisphosphonates (BPs), also inhibit bone formation, while the anabolic agent, teriparatide, does not inhibit bone resorption, and thus they have limited efficacy in
Externí odkaz:
https://doaj.org/article/9342ddf34d9e437d96b8b870a032df6e
Autor:
Youliang Ren, Jason Weeks, Thomas Xue, Joshua Rainbolt, Karen L. de Mesy Bentley, Ye Shu, Yuting Liu, Elysia Masters, Philip Cherian, Charles E. McKenna, Jeffrey Neighbors, Frank H. Ebetino, Edward M. Schwarz, Shuting Sun, Chao Xie
Publikováno v:
Bone Research, Vol 11, Iss 1, Pp 1-13 (2023)
Abstract Eradication of MRSA osteomyelitis requires elimination of distinct biofilms. To overcome this, we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and hydroxybisphosphonate-conjugate sitafloxacin (HBCS, BV63072), which achiev
Externí odkaz:
https://doaj.org/article/96b573a5a803436d94a93195b6f70cb2
Publikováno v:
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-7 (2019)
Abstract Background Bisphosphonates (BPs) are a family of molecules characterized by two key properties: their ability to bind strongly to bone mineral and their inhibitory effects on mature osteoclasts and thus bone resorption. Chemically two groups
Externí odkaz:
https://doaj.org/article/1e6238d214f141d5b2107b1073d3a2f7
Autor:
Jesus Delgado-Calle, Teresita Bellido, G. David Roodman, Robert K. Boeckman, Frank H. Ebetino, Venkat Srinivasan, Noriyoshi Kurihara, Jill A. Helms, Pedro L. Cuevas, Sharmin Khan, Meloney Cregor, Rajwinder Lehal, Michele Vigolo, Judith Anderson, Kevin McAndrews, Tânia Amorim, Manish Adhikari, Adam J. Ferrari, Hayley M. Sabol
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b87d40b4c82e0d8dad5f2fcd50ccaa
https://doi.org/10.1158/0008-5472.22429039
https://doi.org/10.1158/0008-5472.22429039
Autor:
Jesus Delgado-Calle, Teresita Bellido, G. David Roodman, Robert K. Boeckman, Frank H. Ebetino, Venkat Srinivasan, Noriyoshi Kurihara, Jill A. Helms, Pedro L. Cuevas, Sharmin Khan, Meloney Cregor, Rajwinder Lehal, Michele Vigolo, Judith Anderson, Kevin McAndrews, Tânia Amorim, Manish Adhikari, Adam J. Ferrari, Hayley M. Sabol
Systemic inhibition of Notch with γ-secretase inhibitors (GSI) decreases multiple myeloma tumor growth, but the clinical use of GSI is limited due to its severe gastrointestinal toxicity. In this study, we generated a GSI Notch inhibitor specificall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c216d4dbf4c0bfeaab39222d59538b84
https://doi.org/10.1158/0008-5472.c.6513220.v1
https://doi.org/10.1158/0008-5472.c.6513220.v1
Autor:
Jesus Delgado-Calle, Teresita Bellido, G. David Roodman, Robert K. Boeckman, Frank H. Ebetino, Venkat Srinivasan, Noriyoshi Kurihara, Jill A. Helms, Pedro L. Cuevas, Sharmin Khan, Meloney Cregor, Rajwinder Lehal, Michele Vigolo, Judith Anderson, Kevin McAndrews, Tânia Amorim, Manish Adhikari, Adam J. Ferrari, Hayley M. Sabol
Supplementary figures 1, 2, and 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37655fb03b3ca482cfe7510749a5e572
https://doi.org/10.1158/0008-5472.22429042
https://doi.org/10.1158/0008-5472.22429042